Zhejiang Jiuzhou Pharmaceutical Co., Ltd., commonly referred to as Jiuzhou, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 1995, the company has made significant strides in the development and manufacturing of a diverse range of pharmaceutical products, including active pharmaceutical ingredients (APIs) and finished dosage forms. With a strong operational presence in both domestic and international markets, Jiuzhou is recognised for its commitment to quality and innovation. The company’s core offerings, which include generic drugs and specialty pharmaceuticals, are distinguished by their adherence to stringent regulatory standards and advanced production techniques. Jiuzhou has achieved notable milestones, positioning itself as a trusted name in the industry, and continues to expand its market reach through strategic partnerships and a focus on research and development.
How does Zhejiang Jiuzhou's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Zhejiang Jiuzhou's score of 24 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Zhejiang Jiuzhou Pharmaceutical Co., Ltd. reported total carbon emissions of approximately 206,962 tonnes CO2e, comprising about 4,621 tonnes CO2e from Scope 1 and about 201,747 tonnes CO2e from Scope 2 emissions. This reflects a slight increase from 2021, where emissions were about 4,352 tonnes CO2e for Scope 1 and approximately 177,239 tonnes CO2e for Scope 2, totalling around 181,591 tonnes CO2e. In 2020, the company emitted about 4,020 tonnes CO2e from Scope 1 and around 137,366 tonnes CO2e from Scope 2, resulting in total emissions of approximately 141,386 tonnes CO2e. Zhejiang Jiuzhou has committed to near-term climate targets, although specific reduction targets have not been disclosed. The company is actively engaged in climate initiatives within the pharmaceuticals, biotechnology, and life sciences sector, and is recognised for its commitment to sustainability. However, it has not yet set a net-zero target. The emissions data is not cascaded from any parent organisation, indicating that the figures are independently reported by Zhejiang Jiuzhou.
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | 3,819,730 | 0,000,000 | 0,000,000 |
| Scope 2 | 137,365,610 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Zhejiang Jiuzhou has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


Common questions about Zhejiang Jiuzhou's sustainability data and climate commitments